🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This stu...
Status
Completed
Location
UAB HIVTR-CCR5 Non-Network CRS
Start Date
2017-01-01
Trial ID
NCT02741323
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-08-28
Trial ID
NCT03631732
Treatments Being Tested
The IMPACT Long Covid Treatment clinical study (IMPACT-LC) is testing two r...
Status
Not Yet Recruiting
Location
University of Arizona
Start Date
2026-07-15
Trial ID
NCT06974084
Treatments Being Tested
This substudy is a prospective, observational, open-label, randomised study...
Status
Completed
Location
Fundación IDEAA
Start Date
2012-06
Trial ID
NCT01637233
The purpose of the study is to evaluate the safety, acceptability, and PK/P...
Status
Completed
Location
Magee Women's Hospital of UPMC
Start Date
2015-01
Trial ID
NCT02346084
Treatments Being Tested
The main purpose of this study was to compare the effects on bones of the f...
Status
Completed
Location
31788 Alabama CRS
Start Date
2012-01-17
Trial ID
NCT01400412
This study will examine drug and body interactions in children receiving an...
Status
Completed
Location
Univ. of Alabama Birmingham NICHD CRS (5096)
Start Date
2002-08
Trial ID
NCT00977756
This study will evaluate the efficacy of switching from emtricitabine/tenof...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-05-06
Trial ID
NCT02121795
Treatments Being Tested
The purpose of this pilot study is to determine whether Maraviroc is effect...
Status
Completed
Location
San Francisco General Hospital, Clinical Trials Unit
Start Date
2011-03-09
Trial ID
NCT01276236
Treatments Being Tested
Pre-exposure prophylaxis (PrEP) is a method of preventing HIV infection thr...
Status
Completed
Location
UCLA CARE Center CRS
Start Date
2012-06
Trial ID
NCT01505114